Recruiting studies: Primary Graft Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure
NA · 1 location(s) · NYU Langone Health · NCT06569082 REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Phase 1 · 4 location(s) · University of Oklahoma · NCT03541889 Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
Phase N/A · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT02161783 UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT06047886 Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Ste
EARLY_Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06398457 Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Phase 2/Phase 3 · 2 location(s) · Columbia University · NCT07079735

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.